Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/20/1991 | US5041673 Novel tetralin derivatives |
08/20/1991 | US5041653 Substituted benzamide radiosensitizers |
08/20/1991 | US5041648 Phenylhydrazones of β-ionone |
08/20/1991 | US5041639 Polysubstituted derivatives of naphtalene, their process of preparation and their application in the cosmetic and pharmaceutical fields |
08/20/1991 | US5041638 Alkenoic acid derivatives |
08/20/1991 | US5041635 5(Z)-7-(endo-3-benzenesulfonamidobicyclo[2.2.1]hept-exo-2-yl)-5-heptenoic acid, sodium salt |
08/20/1991 | US5041606 Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines |
08/20/1991 | US5041581 Antitumor agents |
08/20/1991 | US5041580 Novel binuclear platinum complex and antitumor agent comprising this complex as active ingredient |
08/20/1991 | US5041579 Platinum complexes and uses therewith |
08/20/1991 | US5041568 Production of (RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acid and related compounds |
08/20/1991 | US5041567 Human and veterianary medicine; veneral diseases respiratory diseases, bovine mastitis |
08/20/1991 | US5041557 Antiulcer agents |
08/20/1991 | US5041549 Heterocyclic spiro compounds and methods for preparing the same |
08/20/1991 | US5041544 Method of manufacturing moranoline derivatives |
08/20/1991 | US5041462 Novel substituted acetamide compounds and use as anti-allergic agents |
08/20/1991 | US5041461 Nervous system disorders; thiophene-2-carboxyamide derivatives |
08/20/1991 | US5041456 Pharmaceutically useful 3-(indol-3-yl)-1,2,4-oxa- and thiadiazoles substituted in the 5-position by an amino containing group |
08/20/1991 | US5041455 Piperidine compounds and their preparation and use |
08/20/1991 | US5041453 Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 |
08/20/1991 | US5041451 Analgesics, hypotensive agents |
08/20/1991 | US5041450 Treatment of ocular inflammation |
08/20/1991 | US5041448 (4-piperidinylmethyl and -hetero) purines |
08/20/1991 | US5041446 Administering dapirazole |
08/20/1991 | US5041445 Antipsychotic agents |
08/20/1991 | US5041444 Hypoglycemic agents; anticoagulants |
08/20/1991 | US5041443 Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof |
08/20/1991 | US5041441 Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
08/20/1991 | US5041440 Dithiolane derivatives |
08/20/1991 | US5041438 Method for treating retroviral infections with benzodiazepine compounds |
08/20/1991 | US5041437 Monoglyceride of fatty acid having 8 to 12 carbon atoms and/or lactic acid ester of aliphatic alcohol of 12 to 18 carbon atoms |
08/20/1991 | US5041436 1-arylsulphonyl-2-piperidinone derivatives, process and intermediates for the preparation thereof, their application as antispasmodics and compositions containing them |
08/20/1991 | US5041434 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
08/20/1991 | US5041433 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase |
08/20/1991 | US5041431 Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
08/20/1991 | US5041430 Oral anticoagulant/platelet inhibitor low dose formulation |
08/20/1991 | US5041429 Cell activators, circulatory ameliorators and edible compositions |
08/20/1991 | US5041426 Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
08/20/1991 | US5041425 Antitumor agent |
08/20/1991 | US5041424 Epipodophyllotoxin glucoside 4'-phosphate derivatives |
08/20/1991 | US5041288 Method of treating tissue damaged by reperfusion injury |
08/20/1991 | US5041278 Alpha tocopherol-based vesicles |
08/20/1991 | US5041236 Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases |
08/20/1991 | CA2075998A1 4-methyl thiazole derivatives, preparation methods therefor and pharmaceutical compositions containing said derivatives |
08/20/1991 | CA2069087A1 N-phenyl n-alcoxycarbonylalkylglycinamides, their preparation and medicaments containing them |
08/20/1991 | CA2036365A1 Pharmaceutical containing episialo complex carbohydrate |
08/20/1991 | CA1287833C Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones |
08/20/1991 | CA1287832C2 Anti-viral compounds |
08/20/1991 | CA1287802C Pharmaceutical formulation containing cimetidine |
08/18/1991 | CA2036480A1 Diterpenes having immunomodulatory action |
08/17/1991 | WO1991012254A1 Substituted urea compounds and their preparation and use |
08/17/1991 | WO1991012250A1 Novel antiviral and antitumor terpene hydroquinones and methods of use |
08/17/1991 | WO1991012017A1 Heparin neutralization with platelet factor 4 |
08/17/1991 | CA2075957A1 Heparin neutralization with platelet factor 4 |
08/17/1991 | CA2075942A1 Antiviral and antitumor terpene hydroquinones and methods of use |
08/17/1991 | CA2074803A1 Substituted urea compounds and their preparation and use |
08/17/1991 | CA2036523A1 Leukotriene antagonists |
08/17/1991 | CA2036415A1 Therapeutic nucleosides |
08/17/1991 | CA2035710A1 Benzimidazole aqnd azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparatin, synthesis interm ediates and pharmaceutical compositions in which they are prsent |
08/16/1991 | CA2035994A1 Chemical compounds (improvements in) |
08/15/1991 | WO1991012009A1 Use of suramin to treat rheumatologic diseases |
08/15/1991 | WO1991011989A1 LIGHT-RESISTANT FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND AN ALKYL β, β-DIPHENYLACRYLATE OR AN ALKYL α-CYANO-β, β-DIPHENYLACRYLATE |
08/15/1991 | CA2075930A1 Use of suramin to treat rheumatologic diseases |
08/14/1991 | WO1991012252A1 Indole derivatives, their preparation and use |
08/14/1991 | WO1991012006A2 Tumor cell sensitization method |
08/14/1991 | WO1991012002A1 Imidazole angiotensin ii antagonists incorporating a substituted benzyl element |
08/14/1991 | WO1991012001A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
08/14/1991 | WO1991011999A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
08/14/1991 | WO1991011909A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element |
08/14/1991 | EP0441736A2 New 1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow |
08/14/1991 | EP0441598A2 Spiroisoindole compounds |
08/14/1991 | EP0441539A2 Thiazine (or oxazine) derivatives and preparation thereof |
08/14/1991 | EP0441517A2 Tricyclic amines as novel cholinesterase inhibitors |
08/14/1991 | EP0441515A1 Tetralin and chroman derivatives in the treatment of asthma, arthritis and related diseases |
08/14/1991 | EP0441506A2 Neuroprotective 3-piperidino-4-hydrosychroman derivatives |
08/14/1991 | EP0441475A2 Baquiloprim for treating protozoal infections |
08/14/1991 | EP0441467A1 Side chain homologes of vitamin D derivatives, process for their preparation, pharmaceutical compositions containing them and their use as medicines |
08/14/1991 | EP0441349A1 Pyrroloazepine derivatives |
08/14/1991 | EP0441339A1 Substituted triazolopyridazines |
08/14/1991 | EP0441333A1 Pharmaceutical composition |
08/14/1991 | EP0441307A1 Syrup composition |
08/14/1991 | EP0441279A1 Bilobalide phospholipide complexes, their applications and formulations containing them |
08/14/1991 | EP0441278A1 Polysaccharides with immunomodulating properties from astragalus membranaceus and pharmaceutical compositions containing them |
08/14/1991 | EP0441218A2 Anthracycline-glycosyl prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates |
08/14/1991 | EP0441119A2 The use of L-Arginine in the treatment of hypertension and other vascular disorders |
08/14/1991 | EP0441106A2 Thyroxine in restoring neuronal plasticity |
08/14/1991 | EP0441036A2 Quinoline derivatives, processes for their preparation, intermediates, and pharmaceutical compositions containing these derivatives |
08/14/1991 | EP0441003A2 Ophthalmic medication |
08/14/1991 | EP0440887A1 Improvement in the total synthesis of Erbstatin analogs |
08/14/1991 | EP0440885A1 Combinations of compounds isolated from curcuma SPP as anti-inflammatory agents |
08/14/1991 | EP0440851A1 Use of buspirone for the treatment of depressions |
08/14/1991 | EP0440811A1 Composition for percutaneous administration |
08/14/1991 | EP0440809A1 Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient |
08/14/1991 | EP0440772A1 Nucleic acid fragments and diagnostic reagents derived from the hhv6/sie genome and procedures for diagnosing hhv6 infections. |
08/14/1991 | EP0440731A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs |
08/14/1991 | EP0440715A1 Topical ointment |
08/14/1991 | EP0440670A1 Heterocyclic acetylenic amines having central nervous system activity. |
08/14/1991 | EP0440626A1 Synthetic gtf chromium material and process therefor |
08/14/1991 | EP0344197B1 Novel n-1 substituted beta-lactams as antibiotics |
08/14/1991 | EP0302896B1 N-(w-substituted alkyl)-n'-[(imidazole-4-yl)alkyl]guanidine |